
Shares of Tylenol-maker Kenvue KVUE.N fall 6.8% to $22.07, the biggest decliner among S&P 500 .SPX constituents
KVUE execs say at a Deutsche Bank conference that retailers have been de-stocking products in China and U.S. due to tariff-related uncertainty
Co says the tariff environment created a lot of uncertainty for retailers, leading to immediate actions with shipments "definitely trailing consumption" in Q2
Co expects a gross tariff impact of around $150 million for 2025, though they mentioned seeing "a slight positive on the China front" since their previous update - conf
Kenvue expects Q2 to be "not materially different from Q1" - conf
Including session moves, stock up 4.8% YTD